Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
0(0%)
Results Posted
25%(1 trials)

Phase Distribution

Ph phase_2
1
25%
Ph phase_1
1
25%
Ph early_phase_1
1
25%

Phase Distribution

2

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution3 total trials
Early Phase 1First-in-human
1(33.3%)
Phase 1Safety & dosage
1(33.3%)
Phase 2Efficacy & side effects
1(33.3%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Completed(4)

Detailed Status

Completed4

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Early Phase 11 (33.3%)
Phase 11 (33.3%)
Phase 21 (33.3%)

Trials by Status

completed4100%

Recent Activity

0 active trials
Showing 4 of 4
completedearly_phase_1

Brain Dopamine Function in Human Obesity

NCT03648892
completedphase_1

Decision Making Study in Young and Middle-Aged Adults: Part II

NCT03512171
completedphase_2

PET Imaging of Dopamine in Healthy Study Participants

NCT00062946
completed

PET-CT Scan Method to Monitor Pancreatic B-Cell Loss in Diabetes Mellitus

NCT00633763

Clinical Trials (4)

Showing 4 of 4 trials
NCT03648892Early Phase 1

Brain Dopamine Function in Human Obesity

Completed
NCT03512171Phase 1

Decision Making Study in Young and Middle-Aged Adults: Part II

Completed
NCT00062946Phase 2

PET Imaging of Dopamine in Healthy Study Participants

Completed
NCT00633763

PET-CT Scan Method to Monitor Pancreatic B-Cell Loss in Diabetes Mellitus

Completed

All 4 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
4